Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Deltex reaps benefit of NICE recommendation

Blood monitoring specialist Deltex Medical saw sales rise in the first half of this year thanks to growing market acceptance of its CardioQ-ODM product for managing surgery patients.

The Aim-listed firm saw overall sales cross the £3 million mark for the six months ended 30 June 2011, up by around £100,000 on the same period last year.

The company also announced that the increased adoption of CardioQ-ODM in the UK had generated over £400,000 in additional revenue, but that this was partly offset by a reduction in sales of monitors in the Middle East.

In March, the National Institute for Health and Clinical Excellence (NICE) published guidance to the NHS in England recommending CardioQ-ODM for use in almost all major and high risk surgery. Commenting on this development, Deltex said the company's UK success was dependent on “the rate of growth in surgical probe sales”. It added that “this has increased since the NICE recommendation”.

However, turning to its international ambitions, the firm pointed out that in the US, clinical awareness of optimising vascular fluids among surgery patients “remains some way behind the UK and continental Europe”.

It also said that as a result of uncertainties caused by political unrest in the Middle East, the company has redeployed some of its resources to other potential markets with developed healthcare systems, including Scandanavia, Canada and Australia. Deltex chairman Nigel Keen claimed the firm is well-positioned to roll-out the CardioQ-ODM “into a number of export markets”. 

Posted on: 18/07/2011

Latest news stories

18/04/2019
Melqart Asset Management has taken a 5% stake in private hospital operator Spire Healthcare.
18/04/2019
Less than half of the public are aware they can choose where they receive NHS-funded hospital treatment, according to a poll by Populus.
17/04/2019
Anchor Hanover has appointed energy, services and regeneration provider Engie as a strategic delivery partner, in a 10-year deal worth £80 million.
16/04/2019
Retirement living developer Birchgrove has launched a new rental-only retirement scheme in Sidcup, Southeast London.
16/04/2019
The Care Quality Commission has rated domiciliary care provider The Good Care Group as outstanding across the five categories it uses to assess performance.


Civica


HealthInvestor blog
With our politicians seemingly absent without leave, the UK desperately needs leadership in policy matters that influence investment decisions

Click here to view the HealthInvestor blog


Singapore’s Pan Pacific Hotel was the venue for HealthInvestor Asia’s February seminar on ‘Expansion strategies for ASEAN healthcare providers’.
A thespian and educator at home in a hazmat suit, with culinary prowess, an eye for improvement and a passion for caring for the elderly
In uncertain times, healthcare real estate remains a steady investment prospect. As the population ages and demand for modern care facilities continues to grow, Kenneth MacKenzie, founder and managing partner of Target Healthcare REIT, tells Marie Cahalane of the importance of a holistic approach to care delivery
Catherine Gooderham highlights some of the opportunities and challenges attracting various investors into a market with guaranteed funding – specialist care
Private equity-backed specialist provider Orbis Education & Care is proving popular with service users, families and commissioners by providing top-quality care in a challenging sector. Rob Munro talks to chief executive Mike Currier about what make this Welsh company such a success and its plans to expand into England

Click here to search all feature articles



Digital technology
The NHS App was supposed to be a gateway for patients to access primary care services and was seen as an opportunity for investors to engage with a health service eager to digitise. Things haven't quite gone to plan. HealthInvestor UK investigates
Read more


Christie + Co

my images



Blockchain

Blockchain is a disruptive force; its entry into the healthcare sector has been gradual, but has the potential to be transformational. Jeremy Bowden considers its implications and applications
Read more